IGF-I STIMULATES GRANULOSA CELL-DERIVED INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-5 - EVIDENCE FOR MEDICATION VIA TYPE-I IGF RECEPTORS

被引:14
作者
ADASHI, EY
RESNICK, CE
ROSENFELD, RG
机构
[1] UNIV MARYLAND, SCH MED, DEPT PHYSIOL, BALTIMORE, MD 21201 USA
[2] STANFORD UNIV, MED CTR, STANFORD, CA 94305 USA
关键词
RECEPTOR; INSULIN GROWTH FACTOR; BINDING PROTEIN-5;
D O I
10.1016/0303-7207(94)90018-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although the precise role of insulin-like growth factor binding proteins (IGFBPs) in ovarian physiology remains a matter of study, existing data suggest a possible antigonadotropic role in the context of follicular atresia. Given the above and the need for improved understanding of the regulation of ovarian IGFBPs, we have set out to explore the ability of IGF-I to modulate IGFBP levels in cultured rat granulosa cells. Specifically, granulosa cells (5 x 10(5) viable cells/dish) from immature (23-25 days old), estrogen-primed rats were cultured under serum-free conditions for 72 h in the absence or presence of IGF-I. At the conclusion of this incubation period, media samples were collected and subjected to Western ligand blotting. Treatment with IGF-I (100 ng/ml) resulted in a substantial (P < 0.05) increase in the accumulation of IGFBP-5, the major 28-29 kDa IGFBP species. Subsequent studies revealed this effect of IGF-I to be both dose- and time-dependent. A similar effect was noted for insulin at dose levels 1-10 mu g/ml at which cross-reaction with the type I IGF receptor (but not with IGFBPs) has been amply documented. Des (1-3) IGF-I, a type I receptor-selective ligand with markedly reduced avidity for IGFBPs, proved substantially more potent (as a promoter of IGFBP-5 accumulation) than its native counterpart. In contrast, treatment with IGF-II or [Leu(27)]IGF-II, type II IGF receptor-selective ligands, yielded a more limited effect on IGFBP5 accumulation in keeping with an overall rank order of potency of des (1-3) IGF-I > IGF-I > IGF-II greater than or equal to [Leu(27)]IGF-II. As such, the present findings demonstrate IGF-I to be a potent stimulatory regulator of granulosa cell-derived IGFBP-5 an effect mediated, at least in part, via cognate type I IGF receptors. Given that IGF-I has also previously been shown to effect receptor-independent regulation of the accumulation of IGFBP-5 in this same cell type, it must be concluded that the IGF-I-mediated increase in the accumulation of granulosa cell-derived IGFBP-5 constitutes a complex phenomenon comprising both receptor-dependent and independent phenomena.
引用
收藏
页码:279 / 284
页数:6
相关论文
共 49 条
[21]   DIVERGENT ACTIONS OF PROSTAGLANDIN-E2 AND PROSTAGLANDIN-F2-ALPHA ON THE REGULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 IN LUTEINIZED GRANULOSA-CELLS [J].
GRIMES, RW ;
SAMARAS, SE ;
HAMMOND, JM .
ENDOCRINOLOGY, 1993, 132 (03) :1414-1416
[22]   INSULIN AND INSULIN-LIKE GROWTH-FACTORS (IGFS) STIMULATE PRODUCTION OF IGF-BINDING PROTEINS BY OVARIAN GRANULOSA-CELLS [J].
GRIMES, RW ;
HAMMOND, JM .
ENDOCRINOLOGY, 1992, 131 (02) :553-558
[23]   IMMUNOREACTIVE INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IN THE CULTURE OF HUMAN LUTEINIZED GRANULOSA-CELLS [J].
HAMORI, M ;
BLUM, WF ;
TOROK, A ;
STEHLE, R ;
WAIBEL, E ;
CLEDON, P ;
RANKE, MB .
ACTA ENDOCRINOLOGICA, 1991, 124 (06) :685-691
[24]   BINDING-PROTEINS FOR INSULIN-LIKE GROWTH-FACTORS IN THE HUMAN OVARY - IDENTIFICATION, FOLLICULAR-FLUID LEVELS AND IMMUNOHISTOLOGICAL LOCALIZATION OF THE 29-32 KD TYPE-1 BINDING-PROTEIN, IGF-BP1 [J].
HARTSHORNE, GM ;
BELL, SC ;
WAITES, GT .
HUMAN REPRODUCTION, 1990, 5 (06) :649-660
[25]   BASAL AND REGULATED SECRETION OF INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS IN OSTEOBLAST-LIKE CELLS IS CELL-LINE SPECIFIC [J].
HASSAGER, C ;
FITZPATRICK, LA ;
SPENCER, EM ;
RIGGS, BL ;
CONOVER, CA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (01) :228-233
[26]   ANALYSIS OF SERUM INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS USING WESTERN BLOTTING - USE OF THE METHOD FOR TITRATION OF THE BINDING-PROTEINS AND COMPETITIVE-BINDING STUDIES [J].
HOSSENLOPP, P ;
SEURIN, D ;
SEGOVIAQUINSON, B ;
HARDOUIN, S ;
BINOUX, M .
ANALYTICAL BIOCHEMISTRY, 1986, 154 (01) :138-143
[27]   REGULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 PRODUCTION IN HUMAN GRANULOSA-LUTEAL CELLS [J].
JALKANEN, J ;
SUIKKARI, AM ;
KOISTINEN, R ;
BUTZOW, R ;
RITVOS, O ;
SEPPALA, M ;
RANTA, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (06) :1174-1179
[28]   HUMAN GRANULOSA-CELLS CONTAIN INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN (IGF BP-1) MESSENGER-RNA [J].
KOISTINEN, R ;
SUIKKARI, AM ;
TIITINEN, A ;
KONTULA, K ;
SEPPALA, M .
CLINICAL ENDOCRINOLOGY, 1990, 32 (05) :635-640
[29]   DEVELOPMENT OF SPECIFIC ANTIBODIES TO RAT INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS (IGFBP-2 TO IGFBP-6) - ANALYSIS OF IGFBP PRODUCTION BY RAT GRANULOSA-CELLS [J].
LIU, XJ ;
MALKOWSKI, M ;
GUO, Y ;
ERICKSON, GF ;
SHIMASAKI, S ;
LING, N .
ENDOCRINOLOGY, 1993, 132 (03) :1176-1183
[30]   INSULIN-LIKE GROWTH FACTOR-I (IGF-I) AND TRANSFORMING GROWTH FACTOR-BETA-1 RELEASE IGF-BINDING PROTEIN-3 FROM HUMAN FIBROBLASTS BY DIFFERENT MECHANISMS [J].
MARTIN, JL ;
BALLESTEROS, M ;
BAXTER, RC .
ENDOCRINOLOGY, 1992, 131 (04) :1703-1710